Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov 1;24(11):3815-3824.
doi: 10.31557/APJCP.2023.24.11.3815.

Influence of p16 Protein Immunostaining on Histopathological Features of Pleomorphic Adenoma and Carcinoma ex- Pleomorphic Adenoma

Affiliations

Influence of p16 Protein Immunostaining on Histopathological Features of Pleomorphic Adenoma and Carcinoma ex- Pleomorphic Adenoma

Iana Aragao Magalhaes et al. Asian Pac J Cancer Prev. .

Abstract

The objective of this study was to evaluate the role of p16 in histologic characteristics and transition of Pleomorphic Adenoma (PA) to Carcinoma ex-PA (CxPA). So, 60 PA and 4 CxPA were histologic reviewed based on microscopic characteristics proposed by Hellquist, Triantafyllou and Dulguerov (PA) and Morais, Antony and Toluie (CxPA). Immunostaining for p16 was associated in different parenchyma and stroma of both tumors and Fisher's/chi-square tests and Mann-Whitney test were performed (SPSS v20.0, p<0.05). In PA the periductal cells were predominantly p16- and that ductal and myoepithelial cells showed a significant increase in p16+ cells (p<0.001). In CxPA, none of the cases showed p16+ in periductal cells, most parotid cases showed p16+ in ductal cells, and one case of parotid and the submandibular case showed mild immunostaining for myoepithelial cells. There was a small reduction in p16+ in CxPA compared to PA (p=0.537), but in both tumors there was less p16+ cells in solid stroma than other (p<0.001). The p16+ cases of PA had a higher capsular thickness (p=0.047). So, the loss of p16 immunostaining does not seem to be associated with the transition from PA to CxPA, but in both tumors the loss of p16+ cells are related to microscopic aggressiveness.

Keywords: Adenoma, Pleomorphic; Genes, p16; Salivary gland neoplasms.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest.

Figures

Figure 1
Figure 1
Histological Features and Immunostaining for p16 in PA. A: classic pattern pleomorphic adenoma showing myxoid (a), hyaline (b) and solid (c) stroma; B: classic pattern pleomorphic adenoma showing chondroid (a) and solid (b) stroma; C: hypocellular pattern pleomorphic adenoma showing predominantly myxoid stroma (a); D: hypercellular pattern pleomorphic adenoma showing predominantly solid stoma (a); E: Hypocellular pattern pleomorphic adenoma showing multinodular distribution (a); F: hypocellular pattern pleomorphic adenoma showing partial capsule rupture (a); G: keratin pearl-shaped squamous metaplasia (a); H: crystalloids (a); I: oncocytic metaplasia; J: pigmentations (a); K: positive immunostaining for p16 in luminal ductal cells, and negative in non-luminal ductal cells; L: positive immunostaining for p16 in chondroid stroma; M: positive immunostaining for p16 in myxoid stroma (myoepithelial cells); N: negative immunostaining for p16 in solid stroma
Figure 2
Figure 2
Histological Features and Immunostaining for p16 in CxPA. A: carcinoma ex pleomorphic adenoma hypercellular pattern showing solid stroma (a); B: carcinoma ex pleomorphic adenoma hypercellular pattern showing hyaline (a) and myxoid (b) stroma; C: classical pattern pleomorphic carcinoma ex-adenoma showing large amounts of ductal cells (a); D: carcinoma ex-pleomorphic adenoma showing extensive cellular and nuclear pleomorphism; E: carcinoma ex-pleomorphic adenoma showing keratin pearl (a); F: carcinoma ex-pleomorphic adenoma showing large areas of intratumoral hemorrhage (a); G: positive immunostaining for p16 in luminal ductal cells, and negative in non-luminal ductal cells; H: positive immunostaining for p16 in myxoid stroma (myoepithelial cells); I: negative immunostaining for p16 in solid stroma

Similar articles

References

    1. Ahmedi JR, Ahmedi E, Perjuci F, et al. Pleomorphic Adenoma of Minor Salivary Glands in Child. Med Arch. 2017;71:360–3. - PMC - PubMed
    1. Almeslet AS. Pleomorphic Adenoma: A Systematic Review. Int J Clin Pediatr Dent. 2020;13:284–7. - PMC - PubMed
    1. Andreasen S, Therkildsen MH, Bjørndal K, Homøe O. Pleomorphic adenoma of the parotid gland 1985-2010: A Danish nationwide study of incidence, recurrence rate, and malignant transformation. Head Neck. 2016;38:eE1364–9. - PubMed
    1. Antony J, Gopalan V, Smith RA, Lam AKY. Carcinoma ex pleomorphic adenoma: a comprehensive review of clinical, pathological and molecular data. Head Neck Pathol. 2012;6:1–9. - PMC - PubMed
    1. Bartkowiak E, Piwowarczyk K, Bodnar M, et al. Expression of p16Ink4a protein in pleomorphic adenoma and carcinoma ex pleomorphic adenoma proves diversity of tumour biology and predicts clinical course. J Clin Pathol. 2022;75:605–11. - PMC - PubMed

Substances